Diffuse large B cell lymphoma historical perspective

Diffuse large B cell lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Diagnosis
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Biopsy
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Diffuse large B cell lymphoma historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Diffuse large B cell lymphoma historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Diffuse large B cell lymphoma historical perspective
CDC on Diffuse large B cell lymphoma historical perspective
Diffuse large B cell lymphoma historical perspective in the news
Blogs on Diffuse large B cell lymphoma historical perspective
Directions to Hospitals Treating Diffuse large B cell lymphoma
Risk calculators and risk factors for Diffuse large B cell lymphoma historical perspective

In 1865, Samuel Wilks used the term "Hodgkin's disease" in Annals of medicine on the name of "Thomas Hodgkin" who published a paper on some morbid appearances of absorbent glands and spleen in 1832. Consequently, the other heterogeneous lymph node neoplastic disorder was later named as Non-Hodgkin's Lymphoma (NHL). Non-Hodgkin lymphoma is now one of the leading malignancies worldwide and Diffuse Large b cell Lymphoma (DLBCL) is one of the most common types of Non-Hodgkin Lymphoma

References

Template:WikiDoc Sources